Artificial intelligence is transforming medicine, but what does that mean for breast cancer screening? Researchers at UMass Chan Medical School are exploring how an AI-based tool might help identify ...

A Carnegie Mellon University spinout company aims to identify patients at high risk for lung, liver and pancreatic cancer by ...

Academia Sinica and National Taiwan University (NTU) Hospital have jointly developed PanMETAI, an AI metabolomics platform to detect the early stages of pancreatic cancer. The tabular AI model detects ...

An innovative biotech startup founded by researchers at Washington University School of Medicine in St. Louis has been acquired by Lunit, a leading company in developing AI-based technologies for ...

Optellum, a 2016 spinout from the University of Oxford, has been tapped by the U.K.’s National Health Service (NHS) to use its artificial-intelligence-powered lung cancer diagnostic as part of an ...

Mass General Brigham researchers are betting that the next big leap in brain medicine will come from teaching artificial intelligence to “read” MRI scans in a more flexible way. The team, led by ...

An image-only artificial intelligence (AI) model for predicting the five-year risk of breast cancer provided stronger and more precise risk stratification than breast density assessment, according to ...